The pacemaker and the lead under complaint were not available for analysis.The analysis is thus based on the inspection of the quality documents associated with the manufacture of these devices as well as the data available for evaluation.The manufacturing processes for the pacemaker and the lead were reviewed and all production steps were performed accordingly.There was no sign of any inconsistency during the manufacturing process.Particularly the final acceptance tests proved the devices functions to be as specified.The available data were thoroughly inspected.The reported loss of capture with high rv pacing parameters (4.0 v / 0.4 ms) in bipolar configuration was confirmed.The data from the timeframe in which the pacemaker was programmed to unipolar rv pacing configuration, with 2.4 v / 0.4 ms, show no anomalies.In particular, the impedance trend in unipolar configuration documents normal values.Based on the information available for analysis, the root cause of the clinical observation is not determinable.However, the integrity of the lead may be compromised.There is no indication of a pacemaker malfunction.Should the lead or pacemaker become available for analysis, this investigation will be updated.
|